Current best practice for bladder cancer: a narrative review of diagnostics and treatments

Eva Compérat; Mahul B. Amin; Richard Cathomas; Ananya Choudhury; Maria De Santis; Ashish Kamat; Arnulf Stenzl; Harriet C. Thoeny; Johannes Alfred Witjes

doi:10.1016/S0140-6736(22)01188-6

Current best practice for bladder cancer: a narrative review of diagnostics and treatments

Eva Compérat, Mahul B. Amin, Richard Cathomas, Ananya Choudhury, Maria De Santis, Ashish Kamat, Arnulf Stenzl, Harriet C. Thoeny, Johannes Alfred Witjes

Urology

Research output: Contribution to journal › Review article › peer-review

71 Scopus citations

Abstract

This Seminar presents the current best practice for the diagnosis and management of bladder cancer. The scope of this Seminar ranges from current challenges in pathology, such as the evolving histological and molecular classification of disease, to advances in personalised medicine and novel imaging approaches. We discuss the current role of radiotherapy, surgical management of non-muscle-invasive and muscle-invasive disease, highlight the challenges of treatment of metastatic bladder cancer, and discuss the latest developments in systemic therapy. This Seminar is intended to provide physicians with knowledge of current issues in bladder cancer.

Original language	English (US)
Pages (from-to)	1712-1721
Number of pages	10
Journal	The Lancet
Volume	400
Issue number	10364
DOIs	https://doi.org/10.1016/S0140-6736(22)01188-6
State	Published - Nov 12 2022

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(22)01188-6

Cite this

@article{090747e6029c40d6adb96354305c5de1,

title = "Current best practice for bladder cancer: a narrative review of diagnostics and treatments",

abstract = "This Seminar presents the current best practice for the diagnosis and management of bladder cancer. The scope of this Seminar ranges from current challenges in pathology, such as the evolving histological and molecular classification of disease, to advances in personalised medicine and novel imaging approaches. We discuss the current role of radiotherapy, surgical management of non-muscle-invasive and muscle-invasive disease, highlight the challenges of treatment of metastatic bladder cancer, and discuss the latest developments in systemic therapy. This Seminar is intended to provide physicians with knowledge of current issues in bladder cancer.",

author = "Eva Comp{\'e}rat and Amin, {Mahul B.} and Richard Cathomas and Ananya Choudhury and {De Santis}, Maria and Ashish Kamat and Arnulf Stenzl and Thoeny, {Harriet C.} and Witjes, {Johannes Alfred}",

note = "Funding Information: We would like to thank Andr{\'e} Oszwald (Medical University of Vienna) for proofreading the first draft of the manuscript and technical assistance. Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",

year = "2022",

month = nov,

day = "12",

doi = "10.1016/S0140-6736(22)01188-6",

language = "English (US)",

volume = "400",

pages = "1712--1721",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10364",

}

TY - JOUR

T1 - Current best practice for bladder cancer

T2 - a narrative review of diagnostics and treatments

AU - Compérat, Eva

AU - Amin, Mahul B.

AU - Cathomas, Richard

AU - Choudhury, Ananya

AU - De Santis, Maria

AU - Kamat, Ashish

AU - Stenzl, Arnulf

AU - Thoeny, Harriet C.

AU - Witjes, Johannes Alfred

N1 - Funding Information: We would like to thank André Oszwald (Medical University of Vienna) for proofreading the first draft of the manuscript and technical assistance. Publisher Copyright: © 2022 Elsevier Ltd

PY - 2022/11/12

Y1 - 2022/11/12

N2 - This Seminar presents the current best practice for the diagnosis and management of bladder cancer. The scope of this Seminar ranges from current challenges in pathology, such as the evolving histological and molecular classification of disease, to advances in personalised medicine and novel imaging approaches. We discuss the current role of radiotherapy, surgical management of non-muscle-invasive and muscle-invasive disease, highlight the challenges of treatment of metastatic bladder cancer, and discuss the latest developments in systemic therapy. This Seminar is intended to provide physicians with knowledge of current issues in bladder cancer.

AB - This Seminar presents the current best practice for the diagnosis and management of bladder cancer. The scope of this Seminar ranges from current challenges in pathology, such as the evolving histological and molecular classification of disease, to advances in personalised medicine and novel imaging approaches. We discuss the current role of radiotherapy, surgical management of non-muscle-invasive and muscle-invasive disease, highlight the challenges of treatment of metastatic bladder cancer, and discuss the latest developments in systemic therapy. This Seminar is intended to provide physicians with knowledge of current issues in bladder cancer.

UR - http://www.scopus.com/inward/record.url?scp=85141475116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85141475116&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(22)01188-6

DO - 10.1016/S0140-6736(22)01188-6

M3 - Review article

C2 - 36174585

AN - SCOPUS:85141475116

SN - 0140-6736

VL - 400

SP - 1712

EP - 1721

JO - The Lancet

JF - The Lancet

IS - 10364

ER -

Current best practice for bladder cancer: a narrative review of diagnostics and treatments

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this